drugset / Trial / NCT05587036

Effects of Rifaximin on Gut Microbiota and Emotion

NCT05587036

Phase 2/3 Recruiting 60 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupTriple-blindBasic science

Summary

A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men.

Timeline

Start
2023-02-02
Primary completion
2025-07
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifaximin Other / unclassified 550 mg Oral

Indications

No indication recorded.